Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

AML × Magnesium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Pancreatic Neoplasms 1 Paclitaxel-induced Neuropathy 1 Obesity 1 Neoplasms 1 Insulin Resistance 1 Hyperandrogenism 1 Hirsutism 1 Dyslipidemias 1 Agnosia 1 AML 1

Interventions

ivosidenib 1 Magnesium 1 14-(ethylamino)-8,9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06717958 2025-07-02

PIVOT

Technische Universität Dresden

Phase 2 Recruiting

AML

Data powered by HemOnc (CC BY 4.0) Colophon ⚡